The price of Yupelri varies depending on factors such as insurance coverage, pharmacy, and dosage. It is a prescription medication, and its cost can be significant without insurance.
What are the treatment options for COPD?
COPD treatment aims to manage symptoms, improve quality of life, and reduce exacerbations. Common treatments include bronchodilators, inhaled corticosteroids, pulmonary rehabilitation, and oxygen therapy. Yupelri is a long-acting muscarinic antagonist (LAMA) used to treat COPD [1].
How does Yupelri work for COPD?
Yupelri, with the active ingredientRevefenacin, is an inhaled bronchodilator. It works by relaxing the muscles in the airways, which helps to open them up and make breathing easier [1].
Can I get financial assistance for Yupelri?
For patients who need financial assistance, there may be programs available to help reduce the out-of-pocket cost of Yupelri. These programs can include manufacturer-sponsored savings cards or co-pay assistance. Information regarding such programs is typically available through the drug's official website or by consulting with a healthcare provider or pharmacist [2].
How is Yupelri administered?
Yupelri is administered as a once-daily inhalation using a nebulizer. The recommended dose is 175 mcg inhaled once daily [1].
What is the patent status of Yupelri?
Drug patents, including those for Yupelri, are crucial for determining market exclusivity. Information on drug patents and their expiration dates can be found on resources like DrugPatentWatch.com [3]. The patent landscape for a drug influences when generic versions might become available.
Who manufactures Yupelri?
Yupelri is manufactured by Mylan Pharmaceuticals Inc., a subsidiary of Viatris [1].
What are the side effects of Yupelri?
Common side effects of Yupelri can include nasopharyngitis (common cold), headache, and urinary tract infection. Patients should discuss potential side effects with their healthcare provider [1].
---
Sources:
1. Yupelri (revefenacin) inhalation solution prescribing information. Sunovion Pharmaceuticals Inc.
2. Yupelri Savings Card. Sunovion Pharmaceuticals Inc.
3. DrugPatentWatch.com